Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rivier

Showing results (311-320 of 1,600) with videos related to

Pageof 160
Sort By:
Endocrinology|December 1, 1986
Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the ratF Petraglia, W Vale, C Rivier
Revue Medicale De La Suisse Romande|June 1, 1979
[Reflection upon some ORL cases treated with radiotherapy]P Anex, P Hertig, A Rivier
Current Pharmaceutical Design|September 7, 2012
Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypesAndreas Stengel, Jean Rivier, Yvette Taché
Endocrinology|December 1, 1971
Synthetic TRF (thyrotropin releasing factor) analogues. II. pGlu-N3imMe-His-Pro-NH2: a synthetic analogue with specific activity greater than that of TRF2W Vale, J Rivier, R Burgus
Biochemical and Biophysical Research Communications|February 5, 1973
Pituitary binding sites for ( 3 H)-labelled luteinizing hormone releasing factor (LRF)G Grant, W Vale, J Rivier
Methods in Enzymology|January 1, 1983
Assay of corticotropin releasing factorW Vale, J Vaughan, G Yamamoto, et al.
Endocrinology|April 1, 1991
An inhibitory effects of interleukin-1a on basal gonadotropin release in the ovariectomized rhesus monkey: reversal by a corticotropin-releasing factor antagonistY J Feng, E Shalts, L N Xia, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1990
Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserumJ R Grider, J R Rivier
Peptides|January 5, 2013
Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypesAndreas Stengel, Jean Rivier, Yvette Taché
Revue Medicale De La Suisse Romande|February 1, 1978
[Application of physiological tests in the diagnosis of multiple sclerosis]F Regli, E Rivier, J Wenk
Pageof 160

Showing results (311-320 of 1,600) with videos related to

Sort By:
Pageof 160
Endocrinology|December 1, 1986
Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the ratF Petraglia, W Vale, C Rivier
Revue Medicale De La Suisse Romande|June 1, 1979
[Reflection upon some ORL cases treated with radiotherapy]P Anex, P Hertig, A Rivier
Current Pharmaceutical Design|September 7, 2012
Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypesAndreas Stengel, Jean Rivier, Yvette Taché
Endocrinology|December 1, 1971
Synthetic TRF (thyrotropin releasing factor) analogues. II. pGlu-N3imMe-His-Pro-NH2: a synthetic analogue with specific activity greater than that of TRF2W Vale, J Rivier, R Burgus
Biochemical and Biophysical Research Communications|February 5, 1973
Pituitary binding sites for ( 3 H)-labelled luteinizing hormone releasing factor (LRF)G Grant, W Vale, J Rivier
Methods in Enzymology|January 1, 1983
Assay of corticotropin releasing factorW Vale, J Vaughan, G Yamamoto, et al.
Endocrinology|April 1, 1991
An inhibitory effects of interleukin-1a on basal gonadotropin release in the ovariectomized rhesus monkey: reversal by a corticotropin-releasing factor antagonistY J Feng, E Shalts, L N Xia, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1990
Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserumJ R Grider, J R Rivier
Peptides|January 5, 2013
Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypesAndreas Stengel, Jean Rivier, Yvette Taché
Revue Medicale De La Suisse Romande|February 1, 1978
[Application of physiological tests in the diagnosis of multiple sclerosis]F Regli, E Rivier, J Wenk
Pageof 160